Company News »

Fluidigm’s JunoTM System Wins Gold at the 8th Annual International Design Awards Competition

Business Wire
Share on StockTwits
Published on

Fluidigm Corporation (NASDAQ:FLDM) announced that its JunoTM system, an advanced platform for genotyping and sample prep, was a Gold Award winner in the Industrial and Life Science Design – Medical/Scientific Machinery category at the 8th Annual International Design Awards competition. The International Design Awards (IDA) was created in 2007 to identify and celebrate smart, sustainable multidisciplinary design around the world.

Fluidigm’s new corporate branding and logo received an Honorable Mention in the Corporate Identity category.

Both Juno’s industrial design and the company’s corporate identity brand and logo were designed by fuseproject, an award-winning integrated design and branding firm founded by acclaimed industrial designer Yves B’ehar.

Fluidigm’s decision to reimagine its product design and brand identity stemmed from a belief that scientists don’t check their aesthetic sensibilities at the laboratory door. “The work our customers undertake is simply amazing,” said Gajus Worthington, Fluidigm President and Chief Executive Officer. “We decided that their experience of everything related to Fluidigm should be similarly exceptional.”

That philosophy is helping shape the development and design of new Fluidigm products.

“Our customers are people who appreciate good design, intuitive user interfaces, provocative information, and a company that is willing to strive to go beyond satisfaction,” Worthington added. “They have a really important job, which, if successful, will change the world. We have embraced the challenge to do everything in our power to help them be successful,” he concluded.

About Fluidigm

Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. We sell to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multi-parameter mass cytometry technology, and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.

We use our website (www.fluidigm.com), corporate Twitter account (@Fluidigm), Facebook page (https://www.facebook.com/Fluidigm), and LinkedIn page (https://www.linkedin.com/company/fluidigm-corporation) as channels of distribution of information about our products, our planned financial and other announcements, our attendance at upcoming investor and industry conferences, and other matters. Such information may be deemed material information and we may use these channels to comply with our disclosure obligations under Regulation FD. Therefore, investors should monitor our website and our social media accounts in addition to following our press releases, SEC filings, public conference calls, and webcasts.

For more information, please visit: www.fluidigm.com.

Fluidigm, the Fluidigm logo and Juno are trademarks or registered trademarks of Fluidigm Corporation.

Share on StockTwits